Clinical trials are a crucial part of the development of new medicines. But existing processes are antiquated, and it can take as many as 10 years before a new drug is approved. As demonstrated during the response to the COVID-19 pandemic, efficient influx of vaccines and other innovative solutions is critical for society’s current and future medical needs. Triall is leading the deployment of blockchain-integrated software solutions to accelerate delivery of new drugs to patients. Triall co-founder and CEO Hadil Es-Sbai and co-founder and head of marketing Raymond van der Waal join Santiago Velez, co-founder and division lead of R&D at Block Digital, to talk about the world’s first digital ecosystem for clinical trials and how it will improve reliability and efficiency in the drug-development process. Recorded on March 7, 2022.
Learn more about your ad choices. Visit podcastchoices.com/adchoices)
